Why is Bafna Pharma. falling/rising?

As of 05-Aug, Bafna Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at Rs 84.59, which reflects a decrease of Rs 4.45 or 5.0%. The stock has underperformed its sector by 4.05% today, reaching an intraday low of Rs 84.59. Despite trading volumes showing a rise in delivery volume by 90.37% against the 5-day average, the stock's performance over the past week and month has been negative, with declines of 7.04% and 5.46%, respectively. While the stock remains above its 50-day, 100-day, and 200-day moving averages, it is below its 5-day and 20-day moving averages. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Bafna Pharmaceuticals has underperformed compared to the Sensex, which has only declined by 0.77% over the past week and 3.26% over the past month. Year-to-date, Bafna Pharmaceuticals has shown a positive return of 10.58%, contrasting with the Sensex's 3.29%. However, over the longer term, the stock has significantly lagged behind the benchmark, with a 3-year return of -24.37% compared to the Sensex's 38.23%. This underperformance in the short term, combined with the recent price decline, suggests that investor sentiment may be cautious, contributing to the stock's downward movement.